Catalysts for Alembic Pharmaceuticals Inc
165 tracked
Aug 29, 2013
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 10, 2013
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Apr 22, 2013
approval
ROPINIROLE HYDROCHLORIDE — FDA approval
ropinirole hydrochloride ER
→
Mar 14, 2013
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 21, 2012
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 21, 2012
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Oct 15, 2012
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 4, 2012
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
May 18, 2012
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Mar 15, 2012
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Mar 15, 2012
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Feb 17, 2012
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Mar 30, 2011
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 13, 2011
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Oct 6, 2010
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→